ALLERGOLOGY INTERNATIONAL is a prestigious, peer-reviewed journal dedicated to advancing the field of immunology and allergy research. Published by the Japanese Society of Allergology, this Open Access journal has been democratizing knowledge since 1996, providing a platform for the latest findings and clinical practices in the management of allergic diseases. Its impressive Q1 ranking in both Immunology and Allergy** and **Medicine (miscellaneous)** categories in 2023 highlights its significance in the global scientific community, with a commendable Scopus ranking of #31 out of 233 in the field of immunology. The journal's focus on innovative research, comprehensive reviews, and case studies ensures that it remains a vital resource for researchers, healthcare professionals, and students alike. Situated in Tokyo, Japan, it continues to bridge gaps in allergy-related health information and foster international collaboration among scholars.

Welcome to the Egyptian Journal of Pediatric Allergy and Immunology, a leading academic platform dedicated to the advancement of knowledge in the field of pediatric allergy and immunology. Published by the prestigious Egyptian Society of Pediatric Allergy & Immunology, this journal aims to address the pressing challenges and breakthroughs in the diagnosis, treatment, and management of allergic diseases in children. As a crucial resource for researchers, healthcare professionals, and students, it focuses on disseminating high-quality, peer-reviewed articles that contribute to the global understanding of allergic conditions and immunological responses in pediatric populations. Although the journal is currently not an Open Access publication, it provides a valuable gateway to research findings that can shape clinical practice and influence future investigations. With an emphasis on contributing to improved healthcare outcomes for children suffering from allergy and immunology disorders, the Egyptian Journal of Pediatric Allergy and Immunology stands out as an essential reference in the field.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, published by MOSBY-ELSEVIER, stands as a leading peer-reviewed journal dedicated to advancing the understanding of allergies and immunological conditions. With a notable impact factor and a prominent stature in the academic community, it ranks in the Q1 category for both Immunology and Allergy in 2023, reflecting its significance and high citation rates among researchers. Since its establishment in 1963, the journal has fostered scientific discourse and innovation in the field, positioning itself as an essential resource for both seasoned professionals and emerging scholars. The Scopus rankings underscore its influence, being ranked 12th out of 233 in Immunology and Allergy and 15th out of 236 in Immunology and Microbiology, placing it in the top centile of both categories. The journal aims to disseminate cutting-edge research, reviews, and clinical studies that deepen our understanding of allergic diseases and enhance patient care. While not an open access journal, it provides institutions and individuals with opportunities to stay informed on crucial advancements in the immunological sciences.

The Journal of Cutaneous Immunology and Allergy, published by FRONTIERS MEDIA SA in Switzerland, is an esteemed Open Access platform dedicated to advancing research in the intersecting fields of dermatology, immunology, and allergy. Since its inception in 2018, this journal has provided a vital resource for the dissemination of innovative research findings and critical reviews, enhancing our understanding of cutaneous conditions related to immune responses. Although currently classified in the Q4 quartile in both Dermatology and Immunology & Allergy categories as of 2023, the journal continues to strive for recognition within the scientific community, encouraging collaboration and knowledge sharing among researchers, clinicians, and experts. The journal boasts an E-ISSN of 2574-4593 and is committed to making high-quality research freely accessible to all, thus fostering greater insights into the complexities of skin-related immune disorders. Join us in this journey to explore the forefront of cutaneous research and contribute to the evolving dialogue in this dynamic field.

Postepy Dermatologii i Alergologii is a distinguished Open Access journal published by TERMEDIA PUBLISHING HOUSE LTD, dedicated to advancing the fields of Dermatology and Immunology and Allergy. Since its inception in 2003, this journal has served as a vital platform for researchers and practitioners alike, promoting knowledge sharing and collaboration in Poland and beyond. With a current impact ranking placing it in the Q3 quartile for both Dermatology and Immunology and Allergy categories, it plays a significant role in contributing to academic discourse within these fields. The journal is indexed in Scopus, with respectable rankings reflecting its relevance and quality—#65/142 in Dermatology and #163/233 in Immunology and Allergy. Researchers are encouraged to explore a vast array of innovative studies and reviews, making it an essential resource for anyone seeking to stay at the forefront of dermatological and allergic research. For those interested in discovering groundbreaking findings and contributing to the ongoing dialogue in these disciplines, Postepy Dermatologii i Alergologii offers not only free accessibility but also a commitment to scholarly excellence.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY is a premier peer-reviewed journal published by Elsevier Science Inc, dedicated to advancing the fields of allergy, asthma, and immunology. With its roots dating back to 1995 and with a focus on high-impact research, this journal has established itself as a leading platform for the dissemination of original research, reviews, and clinical studies within these critical areas. The journal boasts an impressive impact factor, supporting its Q2 ranking in both Immunology and Allergy, as well as in Pulmonary and Respiratory Medicine, indicating its significant contribution to the scientific community. Although it does not currently offer open access options, its comprehensive coverage and rigorous peer-review process ensure that published articles are of the highest quality, making it an invaluable resource for researchers, clinicians, and students alike. The Scopus rankings reflect its esteemed position in the academic landscape, providing professionals with access to cutting-edge developments and insights into the management and treatment of allergic and respiratory conditions.

JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY is an esteemed publication dedicated to the fields of Immunology and Allergy, published by ESMON PUBLICIDAD S A in collaboration with the Department of Allergy and Clinical Immunology at the University Clinical Navarra, Spain. With its rich history spanning over three decades since its inception in 1991, this journal has gained prominence in the scientific community, holding a commendable Q2 quartile in Allergy and a Q3 quartile in Immunology. Ranked within the top tiers of its categories according to Scopus, it stands at Rank #80/233 in Immunology and Allergy, and Rank #96/236 in Immunology and Microbiology, indicating its influential role in disseminating cutting-edge research and clinical insights. Though primarily print-focused, the journal strives to bridge gaps in knowledge and contribute to the ongoing dialogue among researchers, professionals, and students in the immunological sciences. The JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY is essential for anyone committed to advancing the understanding of allergic and immunological conditions.

Alergologia Polska - Polish Journal of Allergology, published by TERMEDIA PUBLISHING HOUSE LTD, is a distinguished academic journal dedicated to advancing the field of allergy research and treatment. With the ISSN 2353-3854, this journal serves as an essential resource for professionals, researchers, and students alike, offering a platform for the dissemination of novel findings and comprehensive reviews in allergic diseases. The journal emphasizes open access to ensure widespread availability and engagement within the scientific community. Alergologia Polska aims to enhance the understanding of allergy mechanisms, diagnostics, and management strategies, fostering collaboration and innovation among experts in the field. Set against the vibrant backdrop of Poznań, Poland, this publication not only highlights clinical and experimental research but also promotes interdisciplinary discussions that are pivotal for tackling complex allergic conditions globally.

Asia Pacific Allergy, published by Lippincott Williams & Wilkins, is a prominent academic journal dedicated to advancing research and clinical practice in the fields of dermatology, immunology, and allergy. With its ISSN 2233-8276 and E-ISSN 2233-8268, the journal provides a platform for innovative studies and reviews that cater to an international audience of researchers, healthcare professionals, and students involved in allergy and related disorders. Although it does not currently offer open access to its publications, the journal's robust output from 2015 to 2017 and its ongoing contribution to the literature from 2021 to 2024 showcase the evolving landscape of allergy research in the Asia Pacific region. Recognized in the 2023 Journal Citation Reports, it holds a Q2 ranking in Dermatology and a Q3 ranking in Immunology and Allergy, while its Scopus ranks further emphasize its significance within these domains, positioning it among the top journals in the field. As a source of cutting-edge research, Asia Pacific Allergy plays a vital role in fostering collaboration and knowledge dissemination, ultimately assisting in the betterment of patient care and treatment strategies across the region.

Current Allergy & Clinical Immunology is a vital peer-reviewed journal published by the Allergy Society of South Africa, focused on advancing the field of immunology and allergy medicine. With an ISSN of 1609-3607, this journal offers crucial insights and research findings pertinent to the understanding and treatment of allergic conditions. Operating from South Africa, it features contributions from a diverse range of authors and professionals in the field. Published from 2008 to 2024, the journal plays an essential role in disseminating current knowledge, even as it holds a Q4 ranking in Immunology and Allergy and is positioned at the 4th percentile based on Scopus rankings. While not open access, it remains an important resource for researchers, practitioners, and students looking to stay informed on emerging trends and breakthroughs in allergy and clinical immunology.